Pfizer, BioNTech to supply Canada with COVID-19 vaccine

An Indonesian girl walks past a sign that says

Human trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned pharmaceutical company Bio Farma and China's Sinovac Biotech Ltd, a senior researcher said.

Zydus Cadila's COVID-19 vaccine candidate found safe in early-stage human trials Zydus Cadila said its COVID-19 vaccine candidate was found to be safe and well-tolerated in an early-stage human trial.

Last month Public Services and Procurement Canada issued bids to supply 75 million syringes and other vaccine administration supplies like alcohol swabs and bandages, to be delivered by the end of October.

Even with progress being made and agreements occurring with new partners, the wait for a vaccine may still be a while.

The World Health Organisation (WHO) on Thursday (Aug 6) warned against "vaccine nationalism", saying vaccine-hogging richer countries would not be safe coronavirus havens if poor nations remained exposed.

Moderna Inc MRNA.O said on Wednesday smaller volume agreements for its experimental coronavirus vaccine have been priced in the range of $32 to $37 per dose, higher than the price set by the US deal for Pfizer Inc's PFE.N vaccine candidate. While waiting for the COVID-19 vaccine development, he added, the government was striving to curb virus transmission and the mortality rate.

Tedros had said on Monday that while the coronavirus was the biggest health emergency since the early 20th century, the worldwide race for a vaccine was also "unprecedented".

Canada wasn't the only country to announce a major supply deal Wednesday.

Both Pfizer and Moderna are part of the US government's Operation Warp Speed program to facilitate the development and production of COVID-19 vaccines quickly.

In detail, 139 vaccine candidates are in the preclinical stage, 25 candidates have entered phase I clinical trials, 17 have been in phase II clinical trials, and 7 candidates in phase III clinical trials or almost complete the process. "And, the one that we really want is the one everybody wants at the same time", Gardam told BNN Bloomberg's Anita Sharma in a television interview.

"People might think that if we get a vaccine then everything goes back to normal the way it was before".

"But there really isn't a guarantee at this point", he said.



Other news